Results 111 to 120 of about 25,223 (248)
Excitability of the motor cortex in patients with migraine changes with the time elapsed from the last attack [PDF]
, 2017 BACKGROUND: Motor-evoked potentials (MEPs) produced by single-pulse transcranial magnetic stimulation (TMS) of the motor cortex can be an objective measure of cortical excitability.
COPPOLA, GIANLUCA +6 more
core +1 more source
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective To examine the association between mental health symptoms in youth and their mothers, and youth incident migraine, using prospectively collected, longitudinal data from the “All Our Families” (AOF) cohort study. Background Internalizing mental health symptoms, such as anxiety and depression, whether experienced by a child or his/her ...
Kirsten Sjonnesen +9 more
wiley +1 more source
Pain Catastrophizing in Childhood Migraine: An Observational Study in a Tertiary Headache Center
Frontiers in Neurology, 2019 Background: Migraine is the most common cause of primary headache in children leading to a decrease in the quality of life. During the last decade, pain catastrophizing construct became a major focus of interest in the study and treatment of pain.Aim of ...
Vittorio Sciruicchio +9 more
doaj +1 more source
Myofascial Trigger Points in Children With Tension-Type Headache: A New Diagnostic and Therapeutic Option [PDF]
, 2009 The goal of this pilot study was to evaluate the effect of a trigger point–specific physiotherapy on headache frequency, intensity, and duration in children with episodic or chronic tension-type headache. Patients were recruited from the special headache
Blaschek, Astrid +9 more
core +1 more source
Delayed urticaria during treatment with anti‐CGRP monoclonal antibodies in migraine
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective To characterize clinical presentation and management of urticaria associated with calcitonin gene‐related peptide (CGRP) ‐targeting monoclonal antibodies (mAbs) for migraine prophylaxis. Background CGRP‐targeting mAbs are effective in migraine prophylaxis, but have been associated with hypersensitivity reactions, including urticaria.
Christoph T. Berger +5 more
wiley +1 more source
The Journal of Headache and Pain, 2018 Background Maintenance of effect following treatment with galcanezumab compared to placebo in adult patients with episodic or chronic migraine was evaluated.
Stefanie Förderreuther +4 more
doaj +1 more source
To control or not? A motivational perspective on coping with pain [PDF]
, 2012 Pain relief is often the primordial treatment objective in pain patients. However, an exclusive focus upon pain relief may have costs. Evidence is accumulating that persistent attempts to gain control over pain may, paradoxically, hinder successful ...
Crombez, Geert +5 more
core +1 more source
A 58‐year‐old woman experiencing occasional dizziness, impaired awareness, and deep feeling of fear
Brain Pathology, EarlyView.
Alessandro Selvaggini +5 more
wiley +1 more source
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective This study aimed to evaluate demographic characteristics, treatment effectiveness, and safety outcomes in patients with migraine undergoing anti‐calcitonin gene‐related peptide (CGRP) treatments regarding the presence of autoimmune diseases. Background CGRP has an important role in migraine pathophysiology through neuronal modulation
María Clara García‐Castillo +37 more
wiley +1 more source
Navigating migraine chronicity: the role of environmental risk factors and triggers
Frontiers in NeurologyPurposeMigraine is a prevalent and debilitating neurological condition that can significantly impact an individual’s quality of life. While various genetic and environmental factors contribute to the development and chronification of migraine, the role ...
Hasan Doğan +9 more
doaj +1 more source